about
Leishmanicidal activities of novel methylseleno-imidocarbamatesChipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimensAntitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer modelExpression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate.Novel library of selenocompounds as kinase modulators.Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.Pre-clinical applications of transgenic mouse mammary cancer models.Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasisOverexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histologyMolecular profiling of angiogenesis markers.Prostate cancer and the genomic revolution: Advances using microarray analyses.Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.Alternative splicing: an emerging topic in molecular and clinical oncology.Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patientsIdentification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis.Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.TMPRSS4: an emerging potential therapeutic target in cancer.Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.The challenge of targeting cancer stem cells to halt metastasis.Strategies to design clinical studies to identify predictive biomarkers in cancer research.Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasis.Synthesis and antiproliferative activity of novel selenoester derivatives.Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis.The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.Translating cancer epigenomics into the clinic: focus on lung cancer.Optimization of 100 μm alginate-poly-L-lysine-alginate capsules for intravitreous administration.Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.
P50
Q30389497-9BB49DBA-451E-484C-931A-6B21447C0A71Q30723008-73AF6FD7-D6B4-4572-ABF2-8F9BE120CE72Q33384993-B80CE71F-DBD7-4C52-AC27-6DF0C5976266Q33575434-64516291-777F-472B-9AFD-1E803F1963B4Q33871207-BFF9E3FB-E659-4EDE-9348-8E52C6F16E51Q33973521-762965AD-967D-47CF-BD26-82D01760A223Q34580852-8FF1FBB6-79F8-4A41-994A-C8F2D6AAD433Q35037410-BDFF2AE9-0F35-41E2-94D1-62860DBE1DB1Q35053270-367D7CAA-3302-4585-8333-13BF749FF756Q35623105-0ECFCFAE-4146-49BB-AB30-D290BE571455Q35747435-9FCE2ECF-B29F-4C71-9FBC-3F797060AFBEQ36160363-4A839D0E-5C41-4436-B8F2-D8E341633A45Q36413760-E00150EF-A62E-4B1D-864E-FCA45F0D55DAQ36597275-2CAA6DD3-211C-4CA9-A036-1B5852F6B6A4Q36725183-378D7598-C748-4A51-A3A6-56956904A537Q36774636-53D25744-D719-4223-988F-EE67F601AAEDQ37225665-3B575625-5DC8-4450-BD7F-3040339AF2F8Q37457699-1BEB0783-D717-4634-A3F0-596976646A4EQ37514211-5F159C98-7CCD-4A2A-9F47-E514FD1A00BBQ37559017-9B1217B6-08E4-4767-A8CC-E42CCA219FAAQ37818251-19C3F701-F3EA-4357-BFF1-D90C3E2A2325Q38016208-774F5F69-4195-401B-8892-7ACA71E8E354Q38247387-92F102A2-4C00-41FF-875B-C7EA2126BA06Q38301472-18A86781-7906-4408-A034-3A9BF34A5A20Q38742361-11B35E3B-7A5A-4EA3-88E9-996FC43A3387Q38770451-8DD51CFF-3C71-4BAC-BBB0-B972A1D6458CQ38780446-928015D0-B654-429F-BD4B-0A7D70A357A4Q38801841-E86AB3D7-E204-48BC-B6B8-4211F3F3A2A4Q38821428-178E99A2-3738-480C-89BC-199867E16E20Q38884727-F161F2DC-2938-4E4C-88FD-5F388FBE15F0Q38923300-BCA7401A-93B9-4E07-9076-C8DF18EC6E17Q39037400-CC93C1C5-A021-40AC-A696-7CD3EE7D00D2Q39051247-DC19A92C-1336-43BD-AE0F-43C2CBF2B099Q39211879-11C36857-6FED-444B-BFE1-FB0DD19CBE2CQ39339912-77AAE81A-5A46-4569-BAC2-30404DB587C3Q39394558-CAAC76D0-FD87-4BB5-9B87-2D22A22C3DFBQ39463355-A4FBF061-D91D-4040-8F9B-14E65F05F287Q39548723-3189BA49-F05B-459D-83D6-E2451EAE751FQ39613701-6D119641-44F6-48E5-8B70-367EFE6B6177Q39626275-FD9DEB47-6032-495B-8A78-9106E4952DC4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alfonso Calvo
@ast
Alfonso Calvo
@en
Alfonso Calvo
@es
Alfonso Calvo
@nl
Alfonso Calvo
@sl
type
label
Alfonso Calvo
@ast
Alfonso Calvo
@en
Alfonso Calvo
@es
Alfonso Calvo
@nl
Alfonso Calvo
@sl
prefLabel
Alfonso Calvo
@ast
Alfonso Calvo
@en
Alfonso Calvo
@es
Alfonso Calvo
@nl
Alfonso Calvo
@sl
P106
P1153
35509386100
P21
P31
P496
0000-0003-4074-4242